Trial · NCT03496168
Results by group137
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 137
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Treatment Emergent Adverse Events and Treatment Emergent Serious Adverse Events | Mavacamtem | TEAEs | 13 | Participants | |
| Number of Participants With Treatment Emergent Adverse Events and Treatment Emergent Serious Adverse Events | Mavacamtem | TESAEs | 5 | Participants | |
| Number of Participants Who Had Cardiovascular Death | Mavacamtem | 0 | Participants | ||
| Number of Participants Who Experienced Sudden Death | Mavacamtem | 0 | Participants | ||
| Number of Participants Who Were Hospitalized for Cardiovascular Reasons. | Mavacamtem | 1 | Participants | ||
| Number of Participants With Heart Failure Due to Systolic Dysfunction, Defined as Asymptomatic LVEF < 50% | Mavacamtem | 0 | Participants | ||
| Number of Participants With LVEF < 50% as Measured by Echocardiography. | Mavacamtem | 2 | Participants | ||
| Number of Participants Who Were Experienced Myocardial Infarction | Mavacamtem | 0 | Participants | ||
| Number of Participants With Ventricular Arrhythmias. | Mavacamtem | Ventricular Tachycardia | 1 | Participants | |
| Number of Participants With Ventricular Arrhythmias. | Mavacamtem | Ventricular Fibrilation | 0 | Participants | |
| Number of Participants With Ventricular Arrhythmias. | Mavacamtem | Ventricular Flutter | 0 | Participants | |
| Number of Participants With Ventricular Arrhythmias. | Mavacamtem | Torsades De Pointe | 0 | Participants | |
| Number of Participants Who Experienced Syncope | Mavacamtem | Dizziness | 2 | Participants | |
| Number of Participants Who Experienced Syncope | Mavacamtem | Orthostatic Hypotension | 1 | Participants | |
| Number of Participants Who Experienced Seizures | Mavacamtem | 0 | Participants | ||
| Number of Participants Who Were Experienced Strokes | Mavacamtem | 0 | Participants | ||
| Number of Participants With a Change in QT and QTcF Intervals. | Mavacamtem | Post Baseline QTcF > 450msec | 7 | Participants | |
| Number of Participants With a Change in QT and QTcF Intervals. | Mavacamtem | Post Baseline QTcF > 480msec | 1 | Participants | |
| Number of Participants With a Change in QT and QTcF Intervals. | Mavacamtem | Post Baseline QTcF > 500msec | 1 | Participants | |
| Number of Participants With a Change in QT and QTcF Intervals. | Mavacamtem | Change from Baseline QTcF > 30 msec | 2 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03496168/results